Company Valuation: Elliptic Laboratories ASA

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 2,882 2,295 1,786 1,103 714.9 351.8 - -
Change - -20.36% -22.15% -38.24% -35.2% -50.78% - -
Enterprise Value (EV) 1 2,681 2,129 1,697 1,046 671.8 286.1 303.3 308.6
Change - -20.57% -20.32% -38.34% -35.79% -57.42% 6.02% 1.77%
P/E -252x -71.1x -47.3x 116x -5.14x -12x -60.8x 54.5x
PBR 8.41x 7.04x 5.82x 3.39x 3.8x 1.67x 1.71x 1.64x
PEG - -0x -2.9x -1x 0x 0.1x 0.8x -0x
Capitalization / Revenue 45.7x 44.1x 26.1x 8.36x 6.96x 3.53x 2.93x 2.35x
EV / Revenue 42.5x 40.9x 24.8x 7.93x 6.54x 2.87x 2.52x 2.06x
EV / EBITDA -948x -69.1x -50.6x 41.7x -32.5x -322x 17.5x 8.6x
EV / EBIT -241x -50.5x -34.1x 222x -14.8x -10.9x -37.6x 35.2x
EV / FCF -94.3x -59x - - -29.1x -10.6x -27.6x 154x
FCF Yield -1.06% -1.69% - - -3.44% -9.44% -3.63% 0.65%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 -0.11 -0.31 -0.36 0.09 -1.32 -0.2313 -0.0458 0.0511
Distribution rate - - - - - - - -
Net sales 1 63.04 52.06 68.32 131.9 102.7 99.54 120.3 150
EBITDA 1 -2.829 -30.81 -33.52 25.12 -20.68 -0.8894 17.36 35.89
EBIT 1 -11.14 -42.13 -49.74 4.71 -45.44 -26.28 -8.055 8.765
Net income 1 -11.16 -32.04 -37.85 8.96 -139 -30.08 -6.028 6.793
Net Debt 1 -201 -165.5 -89.72 -57.04 -43.06 -65.79 -48.56 -43.2
Reference price 2 27.750 22.050 17.040 10.480 6.790 2.785 2.785 2.785
Nbr of stocks (in thousands) 103,842 104,074 104,838 105,275 105,287 126,337 - -
Announcement Date 3/10/22 2/17/23 2/15/24 2/27/25 2/26/26 - - -
1NOK in Million2NOK
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
-12.75x3.08x-345.08x-.--% 40.04M
-403.48x7.71x28.81x-.--% 27.93B
19.93x - - - 5.79B
-777.66x0.93x13.73x-.--% 5.52B
65.07x1.95x11.61x-.--% 3.99B
-38.24x4.16x60.87x - 1.34B
23.33x - - - 472M
Average -160.54x 3.57x -46.01x 0% 6.44B
Weighted average by Cap. -337.74x 6.03x 25.62x 0%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA



Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. ELABS Stock
  4. Valuation Elliptic Laboratories ASA